Top 5 Medical Stocks For 2019

PRA Health Sciences (NASDAQ:PRAH)‘s stock had its “overweight” rating reiterated by equities researchers at Barclays in a note issued to investors on Thursday, The Fly reports. They presently have a $115.00 target price on the medical research company’s stock. Barclays’ target price would indicate a potential upside of 9.71% from the company’s previous close.

Several other analysts also recently weighed in on PRAH. BidaskClub downgraded PRA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, April 27th. Zacks Investment Research upgraded PRA Health Sciences from a “sell” rating to a “hold” rating in a research note on Tuesday, May 1st. ValuEngine downgraded PRA Health Sciences from a “buy” rating to a “hold” rating in a research note on Monday, May 7th. Finally, Jefferies Financial Group restated a “buy” rating and issued a $115.00 target price on shares of PRA Health Sciences in a research note on Friday, July 20th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $100.36.

Top 5 Medical Stocks For 2019: Moneygram International, Inc.(MGI)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By ]

    Moneygram (MGI) : “No, you need quality and this one doesn’t have it.”

    Monster Beverage (MNST) : “I think this one has run out of gas so I’m going to say don’t buy. “

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Moneygram International (MGI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Clearline Capital LP bought a new position in shares of Moneygram International Inc (NASDAQ:MGI) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 17,799 shares of the financial services provider’s stock, valued at approximately $153,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Moneygram International (MGI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks For 2019: Forrester Research, Inc.(FORR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Forrester Research (FORR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Forrester Research (NASDAQ:FORR) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.

  • [By Alexander Bird]

    According to a report from Forrester Research Inc. (Nasdaq: FORR), online sales will account for 17% of all retail sales in the United States by 2022.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of Forrester Research (NASDAQ:FORR) from a hold rating to a buy rating in a research note issued to investors on Monday.

Top 5 Medical Stocks For 2019: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday was a tough day on Wall Street, as the Nasdaq Composite led the way lower among major benchmarks. With the market stuck squarely in the quarterly lull between financial reports from well-known companies, investors have little to go on other than macroeconomic and geopolitical news, and uncertainties related to trade and the political tides in Washington acted to weigh on sentiment to start the week. A few companies saw their shares take much larger hits than the overall market, and Nio (NYSE:NIO), Mersana Therapeutics (NASDAQ:MRSN), and Tandem Diabetes Care (NASDAQ:TNDM) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Keith Speights]

    Which were the biggest winners? Tandem Diabetes Care (NASDAQ:TNDM), DexCom (NASDAQ:DXCM), and Senseonics Holdings (NYSEMKT:SENS) stocks enjoyed tremendous success during the first six months of 2018. Here’s why these are the three best diabetes stocks of 2018 so far — and if they’re still smart picks for investors.

  • [By Keith Speights]

    Tandem Diabetes Care (NASDAQ:TNDM), TransEnterix (NYSEMKT:TRXC), and CRISPR Therapeutics (NASDAQ:CRSP) ranked among the biggest healthcare winners for the week. What drove these stocks higher — and are they still buys? Here’s what you need to know about these hot healthcare stocks. 

Top 5 Medical Stocks For 2019: The Blackstone Group L.P.(BX)

Advisors’ Opinion:

  • [By ]

    The market hasn’t had its needed purge yet says Byron Wien, who is Vice Chairman in the Private Wealth Solutions of Blackstone Group (BX) . “We will retest the February lows [in the markets],” Wien, 86, said on a recent call with media. Wien continues to believe the S&P 500 will rally back after testing the lows, charting a path to 3,000 by year end.

  • [By Money Morning Staff Reports]

    Vivint Solar has a long history with one of the top institutional investors in the world: Blackstone Group LP (NYSE: BX). The private-equity giant – with more than $434 billion under management – purchased Vivant in 2012.

  • [By Stephan Byrd]

    Cambridge Investment Research Advisors Inc. lessened its position in Blackstone Group LP (NYSE:BX) by 8.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 157,103 shares of the asset manager’s stock after selling 13,576 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Blackstone Group were worth $5,054,000 as of its most recent SEC filing.

  • [By Chris Lange]

    Blackstone Group L.P. (NYSE: BX) shares dipped on Thursday after the company announced its newest investment. This is a first for Blackstone, moving into the life sciences industry, which it has historically avoided.

Top 5 Medical Stocks For 2019: Kona Grill Inc.(KONA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By Max Byerly]

    Kona Grill (NASDAQ: KONA) and Yum! Brands (NYSE:YUM) are both retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability.

  • [By Logan Wallace]

    News stories about Kona Grill (NASDAQ:KONA) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Kona Grill earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave press coverage about the restaurant operator an impact score of 47.6558176409177 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Leave a Reply

Your email address will not be published. Required fields are marked *